Nektar Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2024
Amgen 2.36 0.35 Sep/2026
Baxter International 0.17 0.03 Sep/2026
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 4.04 0.32 Sep/2026
Cara Therapeutics 0 0 Mar/2025
Cipla 0.97 0.08 Sep/2026
Dr.Reddys Laboratories 0.65 0.06 Sep/2026
Eisai 3.3 0.59 Sep/2026
Eli Lilly 0.58 0.02 Sep/2026
Gilead Sciences 2.18 0.37 Sep/2026
GlaxoSmithKline 2.78 1.93 Sep/2026
Grifols EUR 1.88 0.68 Dec/2025
Karyopharm Therapeutics 0 0 Mar/2025
Merck 2.34 0.28 Sep/2026
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.28 0.18 Sep/2026
Pfizer 6 1.08 Sep/2026
Roche Holding 2.94 0.01 Jun/2026
Takeda 3.46 0.42 Sep/2026